发明名称 |
Cytostatic substances |
摘要 |
<p>2(R or S)-[2R-(S-Hydroxy-hydroxycarbamoyl-methyl)-4-methyl-pentanoylaminel]-2-phenyl-ethanoic acid cyclopenty ester' 2(R or S)-(3S-Hydroxycarbamoyl-2R-isobutyl-hex-5-enoylamino)-2-phenylethanoic acid isopropyl ester; 2(R or S)-[2R-(S-Hydroxycarbamoyl-methoxy-methyl)-4-methyl-pentanoylamino]-3-phenylethanoic acid cyclopentyl ester; 2(R or S-(3S-Hydroxycarbamoyl-2R-isobutyl-hex-5-enoylamino)-2-(4-methoxyphenyl)ethanoic acid cyclopentyl ester; 2(R or S)-(3S-Hydroxycarbamoyl-2R-isobutyl-hex-5-enoylamino)-2-(thien-2-yl)ethanoic acid cyclopentyl ester; and 2(R or S)-(3S-Hydroxycarbamoyl-2R-isobutyl-hex-5-enoylamino)-2-(thien-3-yl)ethanoic acid cyclopentyl ester are cytostatic agents.</p> |
申请公布号 |
CZ20003317(A3) |
申请公布日期 |
2001.03.14 |
申请号 |
CZ20000003317 |
申请日期 |
1998.03.12 |
申请人 |
BRITISH BIOTECH PHARMACEUTICALS LIMITED |
发明人 |
PEARSON LINDSEY ANN;AYSCOUGH ANDREW PAUL;HUXLEY PHILIP;DRUMMOND ALAN HASTINGS |
分类号 |
A61K31/216;A61K31/22;A61K31/38;A61K31/381;A61P35/00;C07C259/06;C07D333/24;(IPC1-7):C07C259/06 |
主分类号 |
A61K31/216 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|